AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Glimp-M 1 Tablet

Prescription Icon
Prescription Required

Marketer

Biochem Pharmaceutical Industries

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glimp-M 1 Tablet

DiaBetaDuo, a dual-action antidiabetic medication, is prescribed for adult patients with type 2 diabetes. This combination therapy effectively manages blood glucose levels. DiaBetaDuo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your glycemic response. Continuous use is crucial, even with controlled blood sugar, as premature discontinuation, without physician consultation, risks elevated glucose levels, potentially leading to complications including renal impairment, visual disturbances, neuropathy, and limb loss. Remember, DiaBetaDuo complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management, as directed by your doctor. Lifestyle modifications are vital for successful diabetes control. The most frequent adverse reaction is hypoglycemia (low blood sugar). Learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Regular meals and carrying a rapid-acting glucose source, such as sugary snacks or juice, are preventative measures. Alcohol consumption increases hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain is a possibility for some users. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal dysfunction. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women should consult their doctor prior to use. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.

Uses of Glimp-M 1 Tablet

Managing type 2 diabetes

Major Benefits of Glimp-M 1 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimp-M 1 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Glimp-M 1 Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimp-M 1 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. A single Glimp-M tablet should be taken with a meal.

How Glimp-M 1 Tablet works:

Glimp-M, a single tablet formulation, unites Glimepiride and Metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea derivative, enhances pancreatic insulin secretion, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, impeding intestinal glucose uptake, and improving insulin responsiveness throughout the body.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimp-M 1 Tablet and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimp-M 1 Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.

Breast feedingBreast feedingUNSAFE

Nursing mothers should avoid Glimp-M 1 Tablet. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimp-M 1 Tablet cautiously, potentially requiring dose modification. Severe kidney disease contraindicates Glimp-M 1 Tablet use. Consult a physician for guidance. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimp-M 1 Tablet cautiously, potentially requiring dosage modification. Medical advice is essential. A reduced initial dose is typically prescribed for those with mild to moderate liver disease; however, its use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimp-M 1 Tablet :

Should you forget a Glimp-M 1 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimp-M 1 Tablet

LabelValue
Potential for Dependence None.
Treatment Category Medication for diabetes

FAQs on Glimp-M 1 Tablet

Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any leftover medication. Prevent accidental ingestion by children, pets, and others.
Lactic acidosis, a serious medical condition characterized by excessive blood lactic acid, is a potential adverse effect of Glimp-M 1 Tablet. This complication, also termed Metformin-associated lactic acidosis (MALA), is infrequent but poses a significant risk to individuals with pre-existing kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, or bradycardia. The appearance of these symptoms necessitates immediate cessation of Glimp-M 1 Tablet intake and prompt medical attention.
Glimp-M 1 Tablet combines Glimepiride and Metformin to manage type 2 diabetes mellitus (DM) in adults. This medication enhances blood glucose control when used with a suitable diet and regular physical activity. Glimepiride's action involves stimulating insulin secretion from the pancreas, thus reducing blood glucose. Metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for treating type 1 DM.
Glimp-M 1 Tablet may cause common side effects including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal pain, diarrhea, and headache. Rare but serious adverse reactions such as lactic acidosis are also possible. Prolonged use might result in vitamin B12 deficiency.
Prolonged Glimp-M 1 Tablet use can indeed lead to Vitamin B12 deficiency by impeding its gastric absorption. This deficiency, if left unaddressed, may manifest as anemia, neurological complications including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive impairment, and ataxia. To mitigate these risks, supplemental Vitamin B12 is recommended annually by some experts.
Indeed, Glimp-M 1 Tablet can induce hypoglycemia (low blood glucose). Manifestations of low blood sugar encompass nausea, headache, irritability, hunger pangs, sweating, vertigo, tachycardia, and feelings of anxiety or tremor. The likelihood increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is advisable.
Combining Glimp-M 1 Tablet and alcohol is unsafe due to the risk of dangerously low blood sugar (hypoglycemia) and a heightened likelihood of lactic acidosis.
Glimp-M 1 Tablet
87
MRP 106
17% off